547 related articles for article (PubMed ID: 25775482)
1. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose.
McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE
IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482
[TBL] [Abstract][Full Text] [Related]
2. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma.
Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ
Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445
[TBL] [Abstract][Full Text] [Related]
3. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
4. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
[TBL] [Abstract][Full Text] [Related]
5. Breath carbonyl compounds as biomarkers of lung cancer.
Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA
Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567
[TBL] [Abstract][Full Text] [Related]
6. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
7. Progress in the development of volatile exhaled breath signatures of lung cancer.
Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P
Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541
[TBL] [Abstract][Full Text] [Related]
8. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers.
Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P
Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420
[TBL] [Abstract][Full Text] [Related]
9. Constructing an E-Nose Using Metal-Ion-Induced Assembly of Graphene Oxide for Diagnosis of Lung Cancer via Exhaled Breath.
Chen Q; Chen Z; Liu D; He Z; Wu J
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17713-17724. PubMed ID: 32203649
[TBL] [Abstract][Full Text] [Related]
10. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
11. Exhaled biomarkers in lung cancer.
Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G
Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608
[TBL] [Abstract][Full Text] [Related]
12. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
13. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath.
Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY
Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415
[TBL] [Abstract][Full Text] [Related]
14. A breath test for malignant mesothelioma using an electronic nose.
Chapman EA; Thomas PS; Stone E; Lewis C; Yates DH
Eur Respir J; 2012 Aug; 40(2):448-54. PubMed ID: 22183490
[TBL] [Abstract][Full Text] [Related]
15. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening.
Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C
Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337
[TBL] [Abstract][Full Text] [Related]
16. Breathprinting and Early Diagnosis of Lung Cancer.
Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
[TBL] [Abstract][Full Text] [Related]
17. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
[TBL] [Abstract][Full Text] [Related]
18. BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes†.
Rocco R; Incalzi RA; Pennazza G; Santonico M; Pedone C; Bartoli IR; Vernile C; Mangiameli G; La Rocca A; De Luca G; Rocco G; Crucitti P
Eur J Cardiothorac Surg; 2016 Apr; 49(4):1112-7; discussion 1117. PubMed ID: 26385981
[TBL] [Abstract][Full Text] [Related]
19. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study.
Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A
Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807
[TBL] [Abstract][Full Text] [Related]
20. Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study.
Tarnoki DL; Bikov A; Tarnoki AD; Lazar Z; Szilagyi BK; Korosi BZ; Horvath T; Littvay L; Losonczy G; Horvath I
J Breath Res; 2014 Mar; 8(1):016001. PubMed ID: 24421262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]